Plasma concentrations of MMP-2, MMP-3, MMP-11, MMP-26, CA125 and the value of the ROMA algorithm expressed in percentages in ovarian cancer patients (OC) begin lesion patients (BL) and healthy subject (HS) are summarized in Table 1 and Figure 1, Figure 2, Figure 3, Figure 4, Figure 5 and Figure 6. This evidence concerns the gene MMP11 and ovarian carcinoma.